|
LOC653566 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.43849426498855E-15 |
| Normal-vs-Stage2 |
4.26020000054983E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
4.647800E-01 |
| Stage1-vs-Stage3 |
6.226500E-04 |
| Stage1-vs-Stage4 |
1.571770E-04 |
| Stage2-vs-Stage3 |
5.417000E-03 |
| Stage2-vs-Stage4 |
1.820910E-03 |
| Stage3-vs-Stage4 |
2.792600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.801820E-04 |
| Normal-vs-Asian |
2.35689245897674E-12 |
| Caucasian-vs-AfricanAmerican |
5.664000E-01 |
| Caucasian-vs-Asian |
3.610000E-01 |
| AfricanAmerican-vs-Asian |
9.191600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.732990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63502544836547E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.34160000015471E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.843400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.125700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.304800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.386000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.209200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.242400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.57699980746418E-10 |
| Classical-VS-Follicular |
7.58499999999884E-05 |
| Classical-VS-Other |
7.903800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.71573866225572E-12 |
| Tall-VS-Other |
5.098200E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.431820E-01 |
| Follicular-VS-Normal |
3.82749999999765E-05 |
| Other-VS-Normal |
1.66924999999152E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07722727907367E-13 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.78840000000836E-05 |
|
|
